Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01179048 · ClinicalTrials.gov registry record · Phase 3
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Phase 3 study, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- Phase 3
- Development phase
- 9,341
- Enrollment target
NCT01179048: Completed Phase 3 study, sponsored by Novo Nordisk A/S.
NCT01179048 is a Phase 3 study that has completed, run by Novo Nordisk A/S. The registered enrollment target is 9,341 participants, above the 771-participant average among 15,282 other Phase 3 trials with a reported enrollment target (1112% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01179048, a Phase 3 study, has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 9,341 participants
- Enrollment target
Study Summary
This trial is conducted in Africa, Asia, Europe, and North and South America. The aim of this trial is to determine the long term effect of liraglutide on cardiovascular events in subjects with type 2 diabetes.
Primary Outcome
Time from randomisation to first occurrence of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke (a composite cardiovascular outcome). The percentage of subjects experiencing a first event of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke (a composite cardiovascular outcome) is presented.
Interventions
- DRUG placebo
- DRUG liraglutide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,341 participants |
| Start Date | 2010-08-31 |
| Est. Completion | 2015-12-17 |
| Phase | Phase 3 |
What the finished NCT01179048 record still lists
NCT01179048 is an interventional study that assigns participants to a tested intervention. Its 9,341 participants enrollment target places it among the larger protocols in the corpus, above the 771-participant average among 15,282 other Phase 3 trials with a reported enrollment target (1112% higher).
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01179048 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01179048 about?
NCT01179048 is a clinical study titled "Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results". This trial is conducted in Africa, Asia, Europe, and North and South America. The aim of this trial is to determine the long term effect of liraglutide on cardiovascular events in subjects with type 2 diabetes.
What is the current status of trial NCT01179048?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 9,341 participants. The study started on 2010-08-31. Estimated completion is 2015-12-17.
What interventions are being tested in trial NCT01179048?
The interventions under investigation include: placebo (DRUG), liraglutide (DRUG).
Who is sponsoring clinical trial NCT01179048?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01179048's enrollment target sits among peer trials
9,341 31st of 2000 higher than 1,970 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06284408 · 9,460 participants · NA
Centralized Screening Unit (CSU) at Montefiore-Einstein
- NCT05080673 · 9,500 participants · NA
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- NCT06946355 · 9,119 participants · NA
Food-based Support for Hospitalized Children and Their Families
- NCT02000089 · 9,000 participants · Phase 3
The Cancer of the Pancreas Screening-5 CAPS5)Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI